For patients with Crohn's disease or ulcerative colitis who have exhausted other treatment options, a new combination therapy ...
Immune checkpoint inhibitors (ICIs) are a type of immunotherapy or cancer treatment that targets specific immune cells known as T cells, which are responsible for eliminating infection. In cancer, T ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Example antibody-drug conjugate A recent experimental treatment may offer a new method to ...
Coramitug is currently being investigated in the phase 3 CLEOPATTRA trial in approximately 1280 patients with ATTR-CM.
Explore effective operational protocols for managing oncology patients, emphasizing multidisciplinary teamwork and proactive strategies to handle treatment toxicities. Successfully implementing ...
Antibody therapy restoring microglial function Lecanemab, already FDA-approved, is one such anti-amyloid antibody therapy designed to target amyloid-beta plaques and slow down the progression of ...
For people with moderate to severe psoriasis, highly targeted antibody-based treatments introduced in the past 10–15 years have been life changing. Inflamed skin covering swathes of the body often ...
Among patients with gouty arthritis initiating urate-lowering therapy, a single subcutaneous injection of firsekibart — an interleukin-1 beta antibody — reduced acute flares more than a daily dose of ...
Mucormycosis or ‘black fungus’, is a fungal infection affecting the sinuses, lungs, brain, and skin. The fungal infection is rare but can be fatal for those with a weakened immune system. Those that ...
Researchers in Japan have discovered a new type of antibody, called an immune-induced TCR-like antibody (iTab), that can selectively suppress harmful T cells without dampening the entire immune system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results